JNJ vs. MRK: Which Healthcare Titan Offers Better Growth Prospects?Zacks Investment Research • 06/11/25
Merck & Co., Inc. (MRK) Presents at Goldman Sachs 46th Annual Global Healthcare Conference TranscriptSeeking Alpha • 06/10/25
RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts sayCNBC • 06/10/25
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstaZenecaCNBC • 06/09/25
U.S. FDA Approves Merck's ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV SeasonBusiness Wire • 06/09/25
Merck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults With HyperlipidemiaBusiness Wire • 06/09/25
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer DrugBenzinga • 06/05/25
Merck to Participate in the 46th Annual Goldman Sachs Global Healthcare ConferenceBusiness Wire • 06/04/25
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCOCNBC • 06/03/25